ESG

The newly independent Pittsburgh Paints Co. unveils its comprehensive TRU-INDUSTRIAL line, aiming to become a single-source supplier in a competitive market.

Amidst fierce debates over elephant numbers, a new science-led approach challenges old ideas, focusing on habitat connectivity and coexistence over culling.

As Republic Grand Ranch enters its final sales phase, a Parade of Homes offers a last look at acreage living in one of Houston's fastest-growing corridors.

Biotech leader H. Martin Seidel joins Odyssey's SAB, a strategic move signaling accelerated development in the competitive autoimmune disease space.

THIRDREALITY's new Smart Soil Moisture Sensor Gen2 promises better durability and connectivity, aiming to perfect data-driven plant care for smart homes.

Vitestro raises $70M from Labcorp and Mayo Clinic to deploy its AI-powered blood-drawing robot, addressing global phlebotomist shortages and care quality.

At CERAWeek 2026, energy infrastructure leader Williams will outline its strategy for leveraging natural gas to power the AI and data center boom.

A new all-optical switch from Salience Labs promises to slash AI datacenter energy use and latency, entering a heated race to redefine AI infrastructure.

After a stellar 2025, Alcoa will provide critical updates on Q1 financial headwinds and its strategy for navigating a complex global aluminum market.

A new study reveals communications pros are gaining unprecedented C-suite power but feel unprepared for an AI-driven future, risking a major talent exodus.

A new strategic partnership aims to solve the data fragmentation crisis in mining and energy, paving the way for true AI-driven efficiency and safety.

PainTEQ's landmark deal, crowned 'Deal of the Year,' showcases a new model for medtech growth and its patient-first mission in pain management.

REPKON USA rebrands as Paligen, signaling a new era of domestic defense manufacturing fueled by a landmark TNT contract and strategic acquisitions.

New analysis of Phase 1 data for NKGen Biotech’s troculeucel suggests cognitive benefits, offering a potential new weapon against neuroinflammation.

As Abundia heads to a key investor conference, it's betting on proven tech and a Gulf Coast hub to transform plastic waste into a profitable energy source.

Promising results for bladder cancer therapy TARA-002, key FDA designations, and a $198M cash runway position Protara for a pivotal year.

With NCQA Prevalidation for its ARC platform, COPE Health Solutions offers health plans a streamlined path to accreditation and a trusted tool for VBC.

A new campaign by Palvella Therapeutics and key partners aims to educate and empower patients with a rare disease, a strategic move ahead of a potential new drug.

Agenus activates a key manufacturing pact with Zydus, scaling production for its promising BOT+BAL cancer therapy ahead of regulatory filings and market launch.

A new drug targeting the root cause of deadly device infections enters a pivotal trial, offering hope to millions and challenging a $20 billion problem.